THE CASE
A 10-month-old girl, Baby A, was admitted to the hospital because of worsening jaundice. She had been diagnosed with biliary atresia at 1 month of age, and a Kasai procedure was performed when she was 10 weeks old. Since then, she had been failing to thrive and had worsening jaundice.
On the current admission, the patient' s weight was 8 kg (,5th percentile). Her abdominal girth was 50 cm with significant hepatomegaly. Her total protein was 6.0 g/dL with an albumin level of 2.5 g/dL. Alkaline phosphatase was 355 U/L, aspartate aminotransferase was 150 U/L, and alanine aminotransferase was 61 U/L. Her total bilirubin level was 20.5 mg/dL with a direct bilirubin of 18.0 mg/dL. Her prothrombin time was 17.0 seconds, partial thromboplastin time was 28.5 seconds, and her international normalized ratio was 1.8. Baby A' s physicians recommended a liver transplant and estimated that, without a transplant, she would not survive another year.
Her parents did not consent to have her listed for a transplant. They believed that God was already healing their infant. They recounted the story of an uncle who had been told that he might need a kidney AUTHORS: David C. Cronin, MD, PhD, a Janet Squires, MD, transplant and who was still alive and doing well 5 years later. Furthermore, they stated that they did not want their child "butchered." They were also concerned about the burden of traveling to a transplant center 5 hours from their home for the procedure.
Their physician was deeply disturbed by this decision. She felt that a liver transplant was the standard treatment of this condition and that it offered a 90% 5-year survival rate. She believed that it was medical neglect to refuse a liver transplant when the alternative was death within a few months.
The physician requested an ethics consultation, asking whether it was permissible for the parents to refuse a liver transplant in this situation and, if not, whether the ethics committee would support a report to the child protection agency for medical neglect.
David C. Cronin Writes
The field of solid organ transplantation represents an area of medical practice that often must address issues of allocation of a scarce resource, justice, equity, and decisions of who should and who should not be allowed to benefit from the transplantation. In the United States today, aliver transplant is standardof-care for pediatric patients who have end-stage liver disease secondary to biliary atresia. Among pediatric patients, the most common cause of end-stage liver disease and the most common indication for a liver transplant is biliary atresia. The majority of these patients require liver transplantation before the age of 2 years. Legally, the state has an interest in the overall health and life of the most vulnerable members of society; in this case, pediatric patients. Consequently, there are clear mechanisms for health care providers to protect children at risk by taking protective custody and acting on a best interest basis. Here, the prohibition of liver transplantation on a religious basis would not be supported legally. 3 In fact, because this is a child, many social support options exist to facilitate travel, housing support, and pharmaceuticals for the medical therapy.
In the end, it is better to invest the time and effort to educate the family, answer questions, allay their fears, and work collaboratively to embrace the appropriate medical treatment. If unsuccessful, protective custody and prevention of medical neglect are ethically and legally justifiable but would not be an easy path.
Robert Squires Writes
Most children with biliary atresia have jaundice that begins in the first few weeks of life. Often, families assume that the problem is due to "normal newborn jaundice" that just goes away. It is natural to reject the notion that a child may have a serious liver problem when the child "looks okay." From the earliest period of care, parents should be offered a thorough discussion, by using laymen' s terms and drawings, that will review the agespecific etiologies and help them understand what future problems and needs their child may have.
It is not clear to me how this child was "diagnosed" with biliary atresia at age 1 month and had a Kasai procedure at age 10 weeks. The diagnosis of biliary atresia is usually made at the time of an operative cholangiogram, and the Kasai procedure is done immediately by using the same anesthesia. A cholangiogram should only be performed in a center with the surgical capacity to do the appropriate intervention at the same time. I would worry, and try to address, the possibility that there were communication problems at that early stage of treatment.
If biliary atresia is a potential diagnosis, the family must understand some general concepts going into the cholangiogram procedure: (1) biliary atresia is a fatal disease in the absence of a Kasai procedure (the natural history for children who do not have this procedure is that virtually all of them die of their liver disease before their third birthday); (2) after the Kasai procedure, careful and close medical follow-up will be necessary to avoid or manage complications related to biliary atresia (there are some children who live into adulthood with a successful Kasai); (3) not all Kasai procedures are successful; and (4) if the Kasai procedure is not successful, and if the jaundice has not cleared within 3 months after the procedure, then the child' s course will most likely be similar to those who did not receive a Kasai procedure, and an early death can only be averted with a liver transplant.
The Kasai procedure should be performed between 4 and 8 weeks of age. The older the child is at the time of the procedure, the less likely that the child will establish satisfactory biliary drainage.
The months after the Kasai procedure are crucial. The family must have a realistic knowledge of possible outcomes. If the procedure is successful, the elevated bilirubin levelswill fall to the nearnormal or normal range over the next 3 months. In other cases, the liver disease becomes progressive, and the child will need to be considered for liver transplantation. Early referral for a transplant evaluation, even as early as age 5 to 6 months for a child with biliary atresia and a failed outcome on a Kasai procedure, might give the family and child the best opportunity for accessing resources and planning for the future. However, if the parents remain completely opposed to the option of a liver transplant, I cannot accept the inevitability of the death for a child who could be helped by an available medical procedure with reasonable risks. This infant will die without a transplant. I believe such a case should be referred to the child protection authorities, and the judicial system must help decide what will be done.
George Mazariegos Writes
This scenario is a challenging situation. Multidisciplinary evaluation and working closely with the hepatologist seeing the child will help present a unified message to the family. As Dr Squires has emphasized, the key to helping the In this case, despite the fact that this is a young child who is small and who has had a previous failed outcome on a Kasai procedure, this infant would meet the criteria of a child who should do well in an experienced transplant center. Surgical possibilities include a deceased donor transplant, a living donor transplant, and a deceased donor split transplant. Thus, the prospect that this child will attain a suitable transplant in a reasonable time is high.
Pediatric liver transplantation has excellent short-and long-term patient and graft survival outcomes. 4 I would review with the family that the early (1-year) survival is expected to be .90%; in fact, our recent experience shows survival at 98%. 5 Studies of long-term survival, typically defined at 5-and 10-year marks, show survival rates at ∼90%, with most children having highquality life parameters. 6 I would remind parents that biliary atresia is a disease that does not recur after transplant, so that the child is cured of the original problem. The major focus of the care after transplantation is managing the complications of the medicines used for immunosuppression. There are major advances in this area, and many transplant recipients have a reasonable expectation to live with low-level immunosuppression. With a functioning liver, the child is expected to improve her nutrition and growth, which are essential for neurologic development. Finally, I would stress to the family the almost certain poor outcome without transplantation.
There is no reasonable expectation that a very symptomatic infant can improve her nutrition and growth or to thrive with the current liver disease. Without a liver transplant, Baby A would not be expected to live beyond age 2 years.
I do note the parents' use of the word "butchered." There is no question that transplant surgery is major and can be traumatizing. However, experienced centers understand the importance of treating the "whole child," and great efforts are made to help the child and family cope. Our center has developed many resources to support families. Our major focus is return to normalcy for the child and family. A great resource for these parents would be to talk with other parents who have experienced a child having a transplant. Although there are clearly challenges and burdens, most families delight in the development and accomplishments of their child who has survived a lethal condition and who now has a real chance for a bright future.
If all of our efforts fail and the parents of this child would continue their refusal of a liver transplant, I would call our hospital' s child protection team. In my assessment, with the known outcome of death for the child without a transplant, the case should be reviewed by child protection authorities, and I would be willing to participate in a legal process in which a judge might make the ultimate decision. I would hope such action would not be necessary.
Janet Squires Writes
Parents are usually the appropriate surrogate medical decision-makers for their own children. We assume that they have the child' s interest at heart and are in the position to decide the best medical treatment. But there are limits. If parents choose a course of treatment that puts the child in imminent danger of harm, then physicians have a legal obligation to report such acts to the child protection system. Few pediatricians hesitate to report findings indicative of physical child abuse or sexual child abuse.
Medical neglect is hard to define. Textbook discussions of medical neglect usually focus on time-limited interventions in which the benefits and risks are fairly easy to describe, such as a lifesaving blood transfusion. This case presents a myriad of more complex issues. Just a few of the complicating factors to be considered include:
Organ transplant involves complex technology. As new procedures and therapies become available, at which point do such interventions go from being "cutting edge" and research, to becoming standard of care?
Organ transplants are not typically curative. The recipient will have a chronic medical condition requiring ongoing medical care, often for a lifetime.
The burden of treatment is significant. Surgery is invasive, and complications are common.
Burden for a family of a child receiving a transplant is very high. Transplant centers may be geographically far from family homes. Parents must often give up work and take time from their other children.
Courts are reluctant to mandate medical treatments that do not have an end point. If a court were to mandate an organ transplant despite parental refusal, who will care for the child afterward?
In this scenario, parents mention a religious belief that God will heal their infant as 1 motive for their decision. Does it matter what parental reasons are given?
Risk/benefit ratios may depend on the center providing the medical care. Outcome measures are not uniform for all centers.
The diagnosis of child medical neglect is mainly dependent on the level of harm the child will suffer from the lack of medical care that a reasonable person would choose; the definition of "reasonable" is obviously challenging. The diagnosis of medical neglect is generally independent of the motivations of the adult. Lack of resources should be recognized and addressed. Understanding other reasons that parents do not choose or provide "reasonable" medical care (eg, religious beliefs, mental health issues, competing family obligations) is important for attempts to work with the family. Fundamentally, however, pediatricians must assess when a child is being significantly harmed by medical choices of a parent or omissions of a parent' s care, and must call it medical neglect.
In this particular case, I also would talk extensively with the parents and try any tactic to incorporate their wishes for their child. If they refused the transplant option, I also believe this is an appropriate case for a judge to decide. I would explain to the parents that a referral to the child protection system is not a criticism of them as parents, nor a challenge to the belief that they love their child. Rather, physicians have a legal obligation to recognize and report cases in which a child is at risk for significant harm. Like the 2 transplant experts, I would do "almost anything" to avoid legal involvement but feel the certain death sentence for this child without intervention is not acceptable.
John D. Lantos Comments
In 1990, there was a case in Saskatchewan, Canada, in which parents refused a liver transplant for their 10-month-old who had biliary atresia. The physicians sought a court order for transplant. The court sided with the parents. 7 I can find no reported cases, since then, in the United States or Canada, in which physicians sought protective custody because parents were refusing a transplant. I suspect that not all parents consent to transplant. Instead, I think that physicians generally do not report such parents for neglect. Why?
The child-centered arguments for overriding such parental refusals, as presented here, are compelling. Without treatment, the child will surely die. With treatment, the chances for a good outcome are excellent. Our reticence to seek protective custody comes, I think, from the dire scarcity of organs. Because there are not enough organs to go around, some people on waiting lists will die awaiting transplant. It seems wrong to force a transplant on an unwilling family if it means that a willing family might go without one. I suspect that such concerns, rather than the complete absence of parental refusals, is the reason why we have not seen court cases involving this situation. This is one of the very few situations in which such concerns about the dire scarcity of a life-saving resource might appropriately tip the balance against a decision that reflects what is clearly in the child' s best interest. As long as people are dying on the waiting list, this is wise health policy.
Dr Mazariegos Responds
I do not believe organ scarcity is a major issue here. Wait list mortality has significantly improved over the past decade (Fig 1) Pretransplant mortality rates among pediatric patients wait listed for a liver transplant; grouped according to age.
FIGURE 2
Pediatric liver transplant rates according to age.
ETHICS ROUNDS
PEDIATRICS Volume 131, Number 1, January 2013in the United States. In fact, the most significant improvement in transplant rate has been in children aged ,1 year (Fig 2) . Therefore, based on the current data, I strongly disagree that organ scarcity might appropriately tip the balance against transplant for this child or be wise health policy given the scenario described here: an otherwise healthy child with a reasonable chance for long-term success.
LESS ANXIETY AT THE HEAD OF THE PACK:
We tend to think that people in leadership positions-whether in business, politics, or the military-are under more stress than those who are not. For some, the perceived stress of a leadership position makes them leery of accepting such a position. However, contrary to popular sentiment, a recent study reported in Forbes (Leadership: September 27, 2012) showed that leaders seem to feel less stress than their subordinates.
Researchers recruited leaders and non-leaders from the Boston area, including adults enrolled in an executive education program at Harvard University. Researchers compared salivary cortisol levels (a biologic marker of stress) and self-reported anxiety levels (a psychological marker of stress) of leaders and non-leaders. Not only did leaders exercise more, smoke less, and wake up earlier, they also had significantly lower cortisol levels and self-reported stress. In a separate study of adults in Harvard executive education programs, those in higher leadership positions had both lower cortisol levels and anxiety when compared to lower level leaders. This effect was significantly moderated by the leaders' perception of control. The results replicate findings in non-human primates. What is not known is what comes first: being worry free and therefore better able to become a leader, or the leadership position and concomitant reduced stress. The researchers postulate that those holding leadership positions perceive greater control in their lives and this perception is responsible for reducing anxiety. So, the next time you resist taking the reins on a project because of potential increased stress, it might be worth recognizing that once you settle into the position, you might find your concerns to be unfounded.
Noted by Leah H. Carr, BS, MS-III
